About | Free Trial

Last Update

2015-11-18T00:00:00.000Z

This profile was last updated on . .

Is this you? Claim your profile.

Wrong Lloyd Kasper?

Dr. Lloyd Kasper H. MD

Professor of Immunology and Microbiology and Medicine

Geisel School of Medicine at Dartmouth

HQ Phone: (603) 653-0734

Geisel School of Medicine at Dartmouth

One Medical Center Dr (HB 7070)

Lebanon, New Hampshire 03756

United States

Find other employees at this company (339)

Background Information

Employment History

Director of the Multiple Sclerosis Center
DHMC

Professor of Medicine ( Neurology ) , Microbiology and Immunology
Dartmouth-Hitchcock Medical Center

Speaker , Teva Neuroscience , Bayer
Teva Neuroscience , Inc.

Consultant
EMD Serono , Inc.

Medical Director
DHMC

Affiliations

Co-Founder
Symbiotix Inc

Advisory Board Member
Prime Inc

Education

M.D.

Web References (47 Total References)


Dr. Lloyd ...

www.psychosomatic.org [cached]

Dr. Lloyd Kasper

...
Lloyd H Kasper, MD
Dr. Lloyd Kasper is a Professor of Immunology/Microbiology and Medicine at Geisel School of Medicine where he has been actively involved in basic and applied immunology supported by research grants from the National Institutes of Health, March of Dimes, National Multiple Sclerosis Society and industry. He established and directed the Dartmouth MS Center for over 20 years. His basic research interests are related to understanding immunopathogenesis of CNS demyelinating disease, the role of specific immune regulatory populations in disease control and the role of the gut microbiome in CNS demyelination. Dr. Kasper has authored over 175 research and clinical articles related to these interests. He has been the primary organizer for several Keystone Symposia most recently the Microbiome: Effector/Regulatory Networks. When not doing science at Dartmouth, Kasper can be found painting in his studio in Taos, New Mexico.


Biosciences « B2B News

www.tizinc.com [cached]

Symbiotix' lead clinical candidate, Polysaccharide A (PSA), is the first molecule to emerge from the microbiome and the $2.3 million NIH award enables the completion of key translational studies and production of material needed to take into human clinical trials as a novel treatment for multiple sclerosis (MS), said Prof. Lloyd Kasper, Professor of Medicine, Microbiology and Immunology at Geisel School of Medicine at Dartmouth College, and Co-Founder of Symbiotix.

PSA is a first-in-class oral therapy that works through a novel mechanism of action related to activation of regulatory T cells, which exert an anti-inflammatory effect through the production of IL-10.
"Current FDA-approved therapies for multiple sclerosis offer only partial benefit for reduction of relapses and time to disability. However, all of these FDA-approved treatments have side effects some of which can be rather profound," said Prof. Kasper. "We are developing PSA as a safe and effective new oral therapy for the over 500,000 US patients with multiple sclerosis.


Biosciences « B2B News

pr.tizinc.com [cached]

Symbiotix' lead clinical candidate, Polysaccharide A (PSA), is the first molecule to emerge from the microbiome and the $2.3 million NIH award enables the completion of key translational studies and production of material needed to take into human clinical trials as a novel treatment for multiple sclerosis (MS), said Prof. Lloyd Kasper, Professor of Medicine, Microbiology and Immunology at Geisel School of Medicine at Dartmouth College, and Co-Founder of Symbiotix.

PSA is a first-in-class oral therapy that works through a novel mechanism of action related to activation of regulatory T cells, which exert an anti-inflammatory effect through the production of IL-10.
"Current FDA-approved therapies for multiple sclerosis offer only partial benefit for reduction of relapses and time to disability. However, all of these FDA-approved treatments have side effects some of which can be rather profound," said Prof. Kasper. "We are developing PSA as a safe and effective new oral therapy for the over 500,000 US patients with multiple sclerosis.


Understanding the microbiota in ...

www.psychosomatic.org [cached]

Understanding the microbiota in neurological diseases - Lloyd H Kasper, MD


W. A. Smith, Inc. New England Finest Auctions

www.wsmithauction.com [cached]

Lot 99: Painted by Dr. Lloyd Kasper, Neurologist and Director of the Multiple Sclerosis Center at DHMC. Dr. Kasper has been painting long before he arrived at Dartmouth Medical School back in 1983. His paintings adorn the walls of his office and the corridors on the 7th floor of the Rubin Building at DHMC. -- Sold for $200

Similar Profiles

Other People with this Name

Other people with the name Kasper

Karl Kasper
Woodard & Curran Inc

Edward Kasper
Bergen County Fire Chief's Association

Judy Kasper
Re/max Allegiance

Cathry Kasper
Corvallis Montessori School

Hope Kasper
City of Middletown

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory